vs
Side-by-side financial comparison of BARFRESH FOOD GROUP INC. (BRFH) and Protalix BioTherapeutics, Inc. (PLX). Click either name above to swap in a different company.
Protalix BioTherapeutics, Inc. is the larger business by last-quarter revenue ($9.1M vs $5.4M, roughly 1.7× BARFRESH FOOD GROUP INC.). BARFRESH FOOD GROUP INC. runs the higher net margin — -14.1% vs -60.3%, a 46.3% gap on every dollar of revenue. On growth, BARFRESH FOOD GROUP INC. posted the faster year-over-year revenue change (94.5% vs -49.9%). Protalix BioTherapeutics, Inc. produced more free cash flow last quarter ($1.6M vs $426.0K). Over the past eight quarters, BARFRESH FOOD GROUP INC.'s revenue compounded faster (38.4% CAGR vs -6.7%).
Barfresh Food Group Inc. is a specialized food and beverage firm that develops, manufactures, and distributes frozen ready-to-blend smoothies, frappes, and related beverage products. Its core client base includes quick service restaurants, K-12 schools, healthcare facilities, and hospitality operators across North America, delivering portion-controlled, easy-to-prepare solutions that cut down on front-of-house preparation work for food service partners.
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease.
BRFH vs PLX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $5.4M | $9.1M |
| Net Profit | $-763.0K | $-5.5M |
| Gross Margin | 2.9% | 49.4% |
| Operating Margin | -28.9% | -51.1% |
| Net Margin | -14.1% | -60.3% |
| Revenue YoY | 94.5% | -49.9% |
| Net Profit YoY | 10.4% | -184.8% |
| EPS (diluted) | $-0.04 | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $5.4M | $9.1M | ||
| Q3 25 | $4.2M | $17.9M | ||
| Q2 25 | $1.6M | $15.7M | ||
| Q1 25 | $2.9M | $10.1M | ||
| Q4 24 | $2.8M | $18.2M | ||
| Q3 24 | $3.6M | $18.0M | ||
| Q2 24 | $1.5M | $13.5M | ||
| Q1 24 | $2.8M | — |
| Q4 25 | $-763.0K | $-5.5M | ||
| Q3 25 | $-290.0K | $2.4M | ||
| Q2 25 | $-880.0K | $164.0K | ||
| Q1 25 | $-761.0K | $-3.6M | ||
| Q4 24 | $-852.0K | $6.5M | ||
| Q3 24 | $-513.0K | $3.2M | ||
| Q2 24 | $-1.0M | $-2.2M | ||
| Q1 24 | $-449.0K | — |
| Q4 25 | 2.9% | 49.4% | ||
| Q3 25 | 36.7% | 53.4% | ||
| Q2 25 | 31.1% | 62.5% | ||
| Q1 25 | 30.7% | 19.1% | ||
| Q4 24 | 26.2% | 78.7% | ||
| Q3 24 | 34.6% | 53.4% | ||
| Q2 24 | 34.8% | 29.8% | ||
| Q1 24 | 41.4% | — |
| Q4 25 | -28.9% | -51.1% | ||
| Q3 25 | -6.1% | 11.9% | ||
| Q2 25 | -53.4% | 7.5% | ||
| Q1 25 | -25.2% | -41.0% | ||
| Q4 24 | -29.5% | 39.6% | ||
| Q3 24 | -13.7% | 22.2% | ||
| Q2 24 | -68.6% | -18.0% | ||
| Q1 24 | -15.8% | — |
| Q4 25 | -14.1% | -60.3% | ||
| Q3 25 | -6.9% | 13.2% | ||
| Q2 25 | -54.2% | 1.0% | ||
| Q1 25 | -26.0% | -35.8% | ||
| Q4 24 | -30.6% | 35.6% | ||
| Q3 24 | -14.1% | 18.0% | ||
| Q2 24 | -69.1% | -16.4% | ||
| Q1 24 | -15.9% | — |
| Q4 25 | $-0.04 | $-0.06 | ||
| Q3 25 | $-0.02 | $0.03 | ||
| Q2 25 | $-0.06 | $0.00 | ||
| Q1 25 | $-0.05 | $-0.05 | ||
| Q4 24 | $-0.06 | $0.10 | ||
| Q3 24 | $-0.03 | $0.03 | ||
| Q2 24 | $-0.07 | $-0.03 | ||
| Q1 24 | $-0.03 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $14.7M |
| Total DebtLower is stronger | $766.0K | — |
| Stockholders' EquityBook value | $1.3M | $48.2M |
| Total Assets | $12.8M | $82.3M |
| Debt / EquityLower = less leverage | 0.58× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $14.7M | ||
| Q3 25 | — | $13.6M | ||
| Q2 25 | — | $17.9M | ||
| Q1 25 | — | $19.5M | ||
| Q4 24 | — | $19.8M | ||
| Q3 24 | — | $27.4M | ||
| Q2 24 | — | $23.4M | ||
| Q1 24 | $1.2M | — |
| Q4 25 | $766.0K | — | ||
| Q3 25 | $596.0K | — | ||
| Q2 25 | $176.0K | — | ||
| Q1 25 | $200.0K | — | ||
| Q4 24 | $223.0K | — | ||
| Q3 24 | $246.0K | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $1.3M | $48.2M | ||
| Q3 25 | $1.9M | $52.9M | ||
| Q2 25 | $2.0M | $49.9M | ||
| Q1 25 | $2.8M | $45.2M | ||
| Q4 24 | $578.0K | $43.2M | ||
| Q3 24 | $1.4M | $32.4M | ||
| Q2 24 | $1.7M | $28.6M | ||
| Q1 24 | $2.5M | — |
| Q4 25 | $12.8M | $82.3M | ||
| Q3 25 | $6.8M | $82.3M | ||
| Q2 25 | $3.8M | $78.5M | ||
| Q1 25 | $5.3M | $73.9M | ||
| Q4 24 | $3.3M | $73.4M | ||
| Q3 24 | $3.8M | $61.6M | ||
| Q2 24 | $3.3M | $91.5M | ||
| Q1 24 | $4.7M | — |
| Q4 25 | 0.58× | — | ||
| Q3 25 | 0.31× | — | ||
| Q2 25 | 0.09× | — | ||
| Q1 25 | 0.07× | — | ||
| Q4 24 | 0.39× | — | ||
| Q3 24 | 0.18× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $507.0K | $2.0M |
| Free Cash FlowOCF − Capex | $426.0K | $1.6M |
| FCF MarginFCF / Revenue | 7.9% | 17.8% |
| Capex IntensityCapex / Revenue | 1.5% | 4.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-1.9M | $-13.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $507.0K | $2.0M | ||
| Q3 25 | $-598.0K | $-3.7M | ||
| Q2 25 | $-1.1M | $-5.2M | ||
| Q1 25 | $-506.0K | $-5.1M | ||
| Q4 24 | $-685.0K | $4.0M | ||
| Q3 24 | $5.0K | $4.1M | ||
| Q2 24 | $-780.0K | $-3.6M | ||
| Q1 24 | $-769.0K | — |
| Q4 25 | $426.0K | $1.6M | ||
| Q3 25 | $-650.0K | $-4.2M | ||
| Q2 25 | $-1.1M | $-5.7M | ||
| Q1 25 | $-534.0K | $-5.4M | ||
| Q4 24 | — | $3.6M | ||
| Q3 24 | $-52.0K | $4.0M | ||
| Q2 24 | — | $-3.8M | ||
| Q1 24 | — | — |
| Q4 25 | 7.9% | 17.8% | ||
| Q3 25 | -15.4% | -23.7% | ||
| Q2 25 | -69.8% | -36.2% | ||
| Q1 25 | -18.2% | -53.0% | ||
| Q4 24 | — | 19.6% | ||
| Q3 24 | -1.4% | 22.4% | ||
| Q2 24 | — | -28.1% | ||
| Q1 24 | — | — |
| Q4 25 | 1.5% | 4.4% | ||
| Q3 25 | 1.2% | 2.8% | ||
| Q2 25 | 4.1% | 2.8% | ||
| Q1 25 | 1.0% | 3.0% | ||
| Q4 24 | — | 2.3% | ||
| Q3 24 | 1.6% | 0.5% | ||
| Q2 24 | — | 1.3% | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | -1.58× | ||
| Q2 25 | — | -31.91× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.61× | ||
| Q3 24 | — | 1.27× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BRFH
| Raw And Processed Milk | $2.7M | 51% |
| Other | $2.7M | 49% |
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
